|
Real-time
Euronext Paris
06:35:28 2026-08-21 am EDT
|
5-day change | 1st Jan Change | ||
| 77.71 EUR | -0.10% |
|
+2.93% | -6.03% |
| Aug. 20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| Aug. 20 | Cancer vaccines finally garner the spotlight |  |
| Market Cap | 93.2B 109B 86.96B 79.79B 150B 10,415B 153B 1,032B 402B 5,220B 409B 400B 17,281B | P/E 2026 * |
12.4x | P/E 2027 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 105B 122B 97.61B 89.56B 168B 11,691B 172B 1,158B 451B 5,859B 459B 449B 19,397B | EV / Sales 2026 * |
2.2x | EV / Sales 2027 * | 2x |
| Free-Float |
88.34% | Yield 2026 * |
5.47% | Yield 2027 * | 5.78% |
Last Transcript: Sanofi
| 1 day | -0.03% | ||
| 1 week | +2.98% | ||
| Current month | +4.43% | ||
| 1 month | +1.33% | ||
| 3 months | +0.30% | ||
| 6 months | -3.70% | ||
| Current year | -5.98% |
| 1 week | 75.49 |  | 78.94 |
| 1 month | 72.07 | | 80.18 |
| Current year | 71.25 | | 84.97 |
| 1 year | 71.25 | | 91.15 |
| 3 years | 71.25 | | 110.88 |
| 5 years | 71.25 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/6/26 | Others | Executive/Senior Manager | 55,000 | 0.0045% | ||
| 11/15/25 | Buy | Director | 207 | 0.0000% | ||
| 7/29/25 | Buy | Director | 6 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.04% | +2.98% | -11.09% | -21.17% | 109B | |
| -2.81% | +2.93% | +76.40% | +127.73% | 1,109B | |
| -2.21% | +2.02% | +49.50% | +55.01% | 644B | |
| -1.56% | +4.39% | +25.19% | +74.39% | 463B | |
| -1.49% | +3.13% | +39.50% | +44.00% | 371B | |
| -1.16% | +1.93% | +21.33% | +38.67% | 301B | |
| -0.88% | +4.50% | -0.60% | +12.20% | 256B | |
| -1.95% | +3.80% | +46.31% | +65.66% | 234B | |
| -0.39% | +0.22% | -17.06% | -53.16% | 205B | |
| -2.82% | +3.84% | +20.81% | +89.04% | 178B | |
| Average | -0.96% | +2.88% | +25.03% | +43.24% | 386.99B | |
| Weighted average by Cap. | -1.18% | +3.21% | +41.11% | +67.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.59B 55.59B 44.4B 40.75B 76.56B 5,319B 78.07B 527B 205B 2,666B 209B 204B 8,825B | 50.7B 59.22B 47.31B 43.41B 81.57B 5,666B 83.17B 561B 219B 2,840B 222B 218B 9,402B |
| Net income | 7.94B 9.27B 7.41B 6.8B 12.78B 887B 13.03B 87.9B 34.26B 445B 34.83B 34.07B 1,472B | 9.27B 10.82B 8.65B 7.93B 14.91B 1,036B 15.2B 103B 39.98B 519B 40.64B 39.76B 1,718B |
| Net Debt | 11.42B 13.33B 10.65B 9.77B 18.36B 1,276B 18.73B 126B 49.25B 639B 50.06B 48.97B 2,117B | 8.23B 9.62B 7.68B 7.05B 13.24B 920B 13.5B 91.12B 35.52B 461B 36.1B 35.32B 1,526B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | €77.71 | -0.10% | 297,227 |
| 26-08-20 | €77.79 | -0.98% | 1,406,571 |
| 26-08-19 | €78.56 | +1.15% | 1,787,672 |
| 26-08-18 | €77.67 | +1.32% | 1,971,698 |
| 26-08-17 | €76.66 | +1.51% | 1,083,029 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
